Welcome to our website!

Product Catalog

Rapid Product Index

Recommended Products

Friend Links

Your Location:Home>News Center >> Industry news

FDA Approves Gocovri

FDA Approves Gocovri (amantadine) for the Treatment of Dyskinesia in Parkinsons Disease Patients EMERYVILLE, Calif., Aug. 24, 2017 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that the U.S. Food and Drug Administration (

FDA Approves Besponsa

FDA Approves Besponsa FDA Approves Besponsa (inotuzumab ozogamicin) for Relapsed or Refractory Acute Lymphoblastic Leukemia

Less is More for the Adult Cholera Vaccine

FRIDAY, Aug. 18, 2017 -- Researchers say one dose of cholera vaccine appears to provide about the same protection as the standard two doses, at least for the first six months. They also found that cholera vaccines are highly effective in adults but les

Pot Compound Alters Levels of Seizure Drug in Epilepsy Patients

FRIDAY, Aug. 11, 2017 -- Scientists experimenting with the marijuana compound cannabidiol as an epilepsy treatment must evaluate any interactions with other anti-seizure drugs patients are taking, researchers report. The new research from the Universit

Heart Risk Up if Hospitalized for Pneumonia or Sepsis

FRIDAY, Aug. 11, 2017 -- Adults whove been hospitalized with pneumonia or sepsis have a higher risk of heart disease, a new European study reports. Researchers examined data from nearly 237,000 Swedish men. They were followed from age 18 into middle ag

FDA Approves Vyxeos

FDA Approves Vyxeos (daunorubicin and cytarabine) Liposome for Injection for Certain Types of Poor-Prognosis Acute Myeloid Leukemia